BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Kivo Launches Headless GxP Architecture To Power AI Native Drug Development Workflows

New open architecture connects AI agents, regulated workflows, and human-authenticated action to Kivo’s GxP-compliant platform. Kivo, the unified do...

May 21, 2026 | News

Agilent And A*STAR’s NATi Partner To Advance Next Generation Oligonucleotide Therapeutics Research

Agilent Technologies Inc. announced a two-year research collaboration agreement with Singapore’s Nucleic Acid Therapeutics Initiative (NA...

May 21, 2026 | News

Corti Launches Global Healthcare AI Startup Program Amid Rising Regulatory Pressure Across Europe And The US

As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 r...

May 15, 2026 | News

GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the laun...

May 14, 2026 | News

Daiichi Sankyo Targets Global Top Five Oncology Position By 2035

2.3 trillion yen in oncology revenue to be delivered by 2030 through the launch of 20 new indications across five medicines Identifying breakthrough g...

May 12, 2026 | News

ACROBiosystems Expands Global Licensing Access For HEK293 Functional Cell Lines

ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ...

May 12, 2026 | News

Chance Pharma Advances First NDA Submission In China For Innovative Asthma Therapy CXG87

Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...

May 11, 2026 | News

Rznomics Secures FDA RMAT Designation For RNA Editing Therapy RZ 001 In Liver Cancer

RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, ...

May 11, 2026 | News

Harbour BioMed Secures US FDA Clearance For Phase I Trial Of Bispecific Cancer Antibody HBM7004

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics i...

May 11, 2026 | News

ACROBiosystems Simplifies Global HEK293 Licensing To Accelerate Biopharma R&D Compliance

ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrat...

May 11, 2026 | News

Cartography Biosciences Secures Strategic Investment From Samsung Ventures To Advance Precision Oncology Pipeline

Cartography Biosciences and Samsung Ventures announced a strategic investment to support the advancement of Cartography’s differentiated oncology pip...

May 08, 2026 | News

Ribo And Boehringer Ingelheim Reach Third Milestone In siRNA Collaboration Targeting MASH Therapies

Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) announced the achievement of a further milestone. This marks the th...

May 08, 2026 | News

Ribbon Bio Launches Cell Free DNA Platform And In House MiroMine Kit To Expand Access To Complex Synthetic DNA

Ribbon's launches Synthetic MiroSynth Cell-Free DNA product manufactured without bacterial cloning steps. The company has also launched the MiroMi...

May 07, 2026 | News

Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing

New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical productio...

May 05, 2026 | News

Stay Connected